Document is current

Any future updates will be listed below

The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials

Crossref DOI link: https://doi.org/10.1007/s13300-020-00981-0

Published Online: 2020-12-15

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark